Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 123   

Articles published

SHP 4,518.50 -107.50 (-2.32%)
price chart
Shire plc: US FDA Approves Mydayis[TM] (Mixed Salts of a Single-Entity ...
Shire plc (LSE: SHP, NASDAQ: SHPG) announced today that the U.S. Food and Drug Administration (FDA) has approved MYDAYIS (mixed salts of a single-entity amphetamine product), a once-daily treatment comprised of three different types of ...
BRIEF-Shire plc says US FDA approves Mydayis  Reuters UK
Shire shares rise as US FDA approves use of longer term ADHD drug Mydayis  Proactive Investors UK
Shire hit by broker downgrade prompted by worries over drug-maker's ...
Shares in the FTSE 100 drugs group Shire Plc (LON:SHP) were on offer in morning trade following a recommendation downgrade.
Could Shire PLC (SHPG) Be a Great Stock for Value Investors?
Value investing is easily one of the most popular ways to find great stocks in any market environment. After all, who wouldn't want to find stocks that are either flying under the radar and are compelling buys, or offer up tantalizing discounts when ...
How Analysts Rated Shire PLC (LON:SHP) Last Week?  WeeklyHub
Liberum Capital Reaffirms “Hold” Rating for Shire PLC (SHP)  The Cerbat Gem
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation ...
NEW YORK, June 8, 2017 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Shire plc ("Shire" or the "Company") (NASDAQ: SHPG). Such investors are encouraged to ...
BRIEF-Kamada receives additional milestone payment from Shire PLC
LONDON, June 18 Britain's biggest carmaker Jaguar Land Rover (JLR) will hire 5,000 staff as it boosts its skills in autonomous and electric technology, a welcome business endorsement as Prime Minister Theresa May starts Brexit talks after a botched ...
Shire Investors Have Overreacted To Lialda News
On June 7, Zydus Cadila announced it has received approval for its generic formulation of Shire's Lialda, opening the door to a potential launch in July/August 2017 in the US market.
Shire PLC 41.6% Potential Upside Indicated by Cantor Fitzgerald
Shire PLC using EPIC/TICKER code (LON:SHP) had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' this morning by analysts at Cantor Fitzgerald.
Shire PLC (SHP) Stock Rating Reaffirmed by Deutsche Bank AG  Stock Observer
Shire PLC's (SHP) “Buy” Rating Reaffirmed at Liberum Capital  Transcript Daily
Market Fallers: Associated British Foods plc, BAE Systems plc, Shire PLC
Shares in Associated British Foods plc found using EPIC: LON:ABF has moved down -1.9% or -56 points throughout today's trading session so far.
Shire plc (SHPG) Granted Marketing Authorization from EMA for Veyvondi
Shire plc (NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare diseases, today announced that the European Medicines Agency (EMA) validated the Marketing Authorization Application (MAA) for VEYVONDI to ...
Shire (SHPG) Receives MAA Validation for Veyvondi by EMA  Nasdaq
Biotech Movers: Shire, Bellicum, Organovo  TheStreet.com
Shire Is Significantly Undervalued
Despite a positive newsflow for Shire in the last two months, a valuation check suggests that the risk/reward is still really compelling.